by Crestone, Inc. | Feb 15, 2023 | Information
Developing a drug or a therapeutic regimen is a complex, long, and expensive process. Before a pharmaceutical or biotechnology company can begin marketing its products, it must undergo a rigorous review process to gain approval from the various regulatory authorities...
by Crestone, Inc. | Jan 29, 2023 | Information
The pharmaceutical industry relies heavily on small-molecule drugs to treat a variety of diseases and medical conditions [1]. Their ability to cross biological barriers, modulate multiple biological targets, and be chemically synthesized makes small-molecule drugs...
by Crestone, Inc. | Jan 19, 2023 | Information
Doctors and other healthcare workers in biotech companies in Colorado utilize patient reported outcome measures (PROMs) as a tool to evaluate a patient’s general physical and mental health. These measurements help healthcare practitioners create individualized...
by Crestone, Inc. | Jan 1, 2023 | Information
Vancomycin-resistant enterococci (VRE) are Gram-positive bacteria. Vancomycin-resistant enterococci cause infections in hospitals and other settings and demonstrates intrinsic and acquired antibiotic resistance, VRE are considered a serious threat by the US...
by Crestone, Inc. | Dec 21, 2022 | Information
The word “flagellum” basically means “whip”. Flagellum is a structure that is heavily involved in the locomotion of a cell. The flagellum is a hair-like/thread-like, microscopic structure. It is around five to 16 µm in length and 12 – 30 nm in diameter. Despite being...
